Benzinga | Nov 9, 2021 05:19PM EST

Health Catalyst Q3 EPS $(0.18) Beats $(0.21) Estimate, Sales $61.74M Beat $60.63M Estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.21) by 14.29 percent. This is a 14.29 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $61.74 million which beat the analyst consensus estimate of $60.63 million by 1.83 percent. This is a 30.82 percent increase over sales of $47.19 million the same period last year.